1 / 14

Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Vaccine Briefs Segment

Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Vaccine Briefs Segment. Graphics subject to change. This material in the public domain. Human Papillomavirus (HPV) Vaccine Schedule. Females 9 through 26 years of age Routine schedule is 0, 2, and 6 months

kass
Télécharger la présentation

Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Vaccine Briefs Segment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Vaccine Briefs Segment Graphics subject to change. This material in the public domain.

  2. Human Papillomavirus (HPV) Vaccine Schedule • Females 9 through 26 years of age • Routine schedule is 0, 2, and 6 months • Minimum intervals: • 4 weeks between doses 1 and 2 • 12 weeks between doses 2 and 3 Source: MMWR 2007;56(No. RR-2)

  3. HPV Vaccination ACIP Recommendations • Routine vaccination of females 11-12 years of age with three doses of quadrivalent HPV vaccine • The vaccination series can be started as young as 9 years of age at the clinician’s discretion Source: MMWR 2007;56(No. RR-2)

  4. HPV Vaccination ACIP Recommendations • Vaccination is recommended for females 13 through 26 years of age not previously vaccinated • Vaccine should be administered before onset of sexual activity, if possible • Females who are sexually active should be vaccinated Source: MMWR 2007;56(No. RR-2)

  5. HPV VaccineSpecial Situations • Females 26 years of age or younger with equivocal or abnormal Pap test, positive HPV DNA, or genital warts may be vaccinated • Vaccine will have no effect on existing disease or infection Source: MMWR 2007;56(No. RR-2)

  6. HPV VaccineSpecial Situations • Females 26 years of age or younger who are lactating and breastfeeding, or are immuno-compromised may be vaccinated • NOT recommended for pregnant women Source: MMWR 2007;56(No. RR-2)

  7. HPV Vaccine • HPV vaccine is not approved for women older than 26 years or males • Efficacy data is not yet available for these groups • ACIP does NOT recommend off-label in either women older than 26 years or in males

  8. General Recommendationson Immunization, 2006 • Vaccine administration • Vaccine storage and handling • Altered immunocompetence • Special situations • allergy to vaccine components • pregnancy • vaccines received outside the U.S. • persons with bleeding disorders

  9. General Recommendationson Immunization, 2006 • New or expanded tables • minimum intervals and ages • contraindications and precautions • dose and route of administration • needle length and injection sites • vaccine storage temperatures • vaccine recommendations for persons with immune deficiencies

  10. Twinrix “Accelerated” Schedule • Doses at 0, 7, 21-30 days and a booster dose at 12 months • Approved only for persons 18 years and older • The first THREE doses of the newly- licensed Twinrix schedule provide equivalent protection to • the first dose in the standard, single antigen adult hepatitis A vaccine series • the first two doses in the standard adult hepatitis B vaccine series

  11. Vaccine Information Statements • Every healthcare provider, public or private, who administers a vaccine covered by the National Childhood Vaccine Injury Act is required by law to provide a copy of the most current VIS with EACH DOSE of vaccine

  12. Vaccine Information Statements • Not required by Federal law to obtain a signature • Must note in each patient’s permanent medical record or permanent office file: • date printed on the VIS • date the VIS is given to the vaccine recipient, or their legal representative

  13. Vaccine Information StatementsNew or Revised Since August 2006 • New • Human papillomavirus • Zoster • Revised • DTaP • Hepatitis B • Varicella • Meningococcal • Influenza (TIV and LAIV)

  14. CDC Vaccines and ImmunizationContact Information • Hotline (800) CDC-INFO • Email nipinfo@cdc.gov • Website www.cdc.gov/nip • Broadcast Updates and Resources Web Page www.cdc.gov/vaccines/ed/broadcasts.htm

More Related